News South Asia

Graduate scheme in Nova Nordisk

Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy.

Headquartered in Denmark, Novo Nordisk employs approximately 37,200 employees in 76 countries, and markets its products in more than 180 countries.
Novo Nordisk’s B shares are listed on NASDAQ OMX Copenhagen (Novo-B). Its ADRs are listed on the New York Stock Exchange (NVO)

Novo Nordisk is the world′s 9th biggest pharmaceutical company. We employ more than 35,000 people and experience double digit growth in sales. Join us! Get the chance to use your recently-acquired master′s degree and help change the lives of people with diabetes. Read the graduate programme introduction, check out the 10 programmes, read blogs and apply.